| Identification | Back Directory | [Name]
Tyroservaltide | [CAS]
154039-16-4 | [Synonyms]
YSV
CMS02402
CMS-024-02
CMS 024 02
Tyroservaltide
L-Valine, L-tyrosyl-L-seryl-
(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoic acid | [Molecular Formula]
C17H25N3O6 | [MOL File]
154039-16-4.mol | [Molecular Weight]
367.4 |
| Hazard Information | Back Directory | [Uses]
Tyroservatide (YSV) is an active, low-molecular-weight polypeptide that has been shown to have antitumor effects on hepatocellular carcinoma and lung cancer cell[1]. | [Definition]
ChEBI: Tyr-Ser-Val is an oligopeptide. | [References]
[1] Lin-Xi Shi, et al. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. Cancer Lett. 2008 Sep 28;269(1):101-10. DOI:10.1016/j.canlet.2008.04.033 |
|
|